Court Sees Infringement Of Allergan Glaucoma Patent
A federal court ruled Friday that two generic-drug makers violated patents held by Allergan Inc. for glaucoma treatments using brimonidine....To view the full article, register now.
Already a subscriber? Click here to view full article